Latest Product Launch News

Raiz Invest Limited reported robust growth in Q4 FY25, with active customers and funds under management hitting new highs, supported by a strategic partnership with Drip Invest and ongoing product innovation.

Bod Science Limited reports a dramatic reduction in half-year losses alongside revenue growth driven by a strategic shift to THC products. The company remains under a Deed of Company Arrangement with key corporate actions pending shareholder approval.

icetana Limited reports its strongest quarterly annual recurring revenue growth in over four years, boosted by a landmark $3.6 million strategic partnership with SoftBank Robotics Group and expanding global deployments.

Nuchev Limited reports a record-breaking Q4 FY25 with revenues soaring 167% year-on-year, driven by strong growth across multiple markets and a strategic agency agreement in Australia.

OMG Group Limited has reported a remarkable 253% increase in quarterly cash receipts for Q4 FY25, driving annual revenues up 63% to $4.13 million and positioning the company for further growth in FY26.

BetMakers Technology Group capped FY25 with its strongest quarterly results ever, showcasing record profitability, positive cash flow, and a debt-free balance sheet. The company’s strategic investments and recent capital raise set the stage for accelerated growth in FY26, including a key acquisition in Nevada.

Tinybeans Group Limited has reported a second straight quarter of positive operating cash flow alongside steady subscriber growth and new product launches, signaling a turning point for the family-focused subscription platform.

Integrated Research reports a softer FY25 with declines in contract value and earnings, yet steady underlying revenue and promising AI-driven product launches signal a strategic pivot.

HUB24 Limited has reported a record $19.8 billion in net inflows for FY25, driven by strong platform growth and significant migrations from Equity Trustees. The company also launched an innovative high net worth solution, reinforcing its market leadership.

Atturra Limited reports FY25 underlying EBITDA exceeding $31 million and revenue topping $300 million, setting the stage for a strong growth outlook in FY26 driven by acquisitions and product expansion.

Compumedics Limited has reported record sales orders and a return to profitability in FY25, setting the stage for robust growth in FY26 driven by US market traction and SaaS expansion.

Artrya Limited has secured a five-year, US$0.6 million contract with Tanner Health, marking its inaugural commercial revenue in the U.S. market for its AI-powered Salix Coronary Anatomy platform.